MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.45 -0.11 (-0.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Share-based Compensation (2021 - 2026)

Updated

MoonLake Immunotherapeutics (MLTX) reported Share-based Compensation of $2.55 million for Q2 2026, down 23.1% from $3.31 million a year earlier and down 80.9% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Share-based Compensation (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, MoonLake Immunotherapeutics' Share-based Compensation came in at $23.2 million, up 147.4% year-over-year; for FY2025, it came in at $12.9 million, up 77.1% from FY2024.

  • Share-based Compensation has a five-year compound annual growth rate of 381.2% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $7.28 million in FY2024 (+2.5%), $7.11 million in FY2023 (-26.4%), $9.65 million in FY2022 (+6.6%) and $9.05 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Share-based Compensation since Q1 2025.
  • Year over year, Share-based Compensation gained in seven of the last eight quarters, with growth averaging 101.8%.
  • The high point for year-over-year Share-based Compensation in five years was Q1 2026 (growth of 483.2%); the low point was Q4 2022 (a decline of 56.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $13.36 million (Q1 2026), $3.59 million (Q4 2025) and $3.71 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 MoonLake Immunotherapeutics 983.83 Mn -685.56 Mn - 2.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.55 Mn
Mar 31, 2026 13.36 Mn
Dec 31, 2025 3.59 Mn
Sep 30, 2025 3.71 Mn
Jun 30, 2025 3.31 Mn
Mar 31, 2025 2.29 Mn
Dec 31, 2024 1.93 Mn
Sep 30, 2024 1.84 Mn
Jun 30, 2024 1.83 Mn
Mar 31, 2024 1.68 Mn
Dec 31, 2023 1.61 Mn
Sep 30, 2023 1.43 Mn
Jun 30, 2023 1.50 Mn
Mar 31, 2023 2.58 Mn
Dec 31, 2022 2.60 Mn
Sep 30, 2022 2.59 Mn
Jun 30, 2022 2.48 Mn
Mar 31, 2022 1.99 Mn
Dec 31, 2021 5.95 Mn
Sep 30, 2021 1.86 Mn
API Access

MoonLake Immunotherapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MLTX&period=max&api_key=YOUR_API_KEY